Citations

Mayo Clinic

Showing 10 of 108585 citations.

Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the Reduction by Dutasteride of Prostate Cancer Events study
Feng, Tom , Howard, Lauren E. , Vidal, Adriana C. , Moreira, Daniel M. , Castro‐Santamaria, Ramiro , Andriole, Gerald L. , Freedland, Stephen J. , Vidal, Adriana C. , Howard, Lauren E

International Journal of Urology | December 22, 2016 | Volume: 24 | Issue: 2 | Pages: 151-156

10.1111/iju.13265 | PMID 28004415 Get It

ObjectiveTo determine if cholesterol is a risk factor for the development of lower urinary tract symptoms in asymptomatic men.MethodsA post‐hoc analysis of the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study was carried out in 2323 men with baseline International Prostate Symptom Score <8 and not taking benign prostatic hyperplasia or cholesterol medications. Cox proportion models were used to test the association between cholesterol, high‐density lipoprotein, low‐density lipoprotein and the cholesterol : high‐density lipoprotein ratio with incident lower urinary tract symptoms, defined as first report of medical treatment, surgery or two reports of an International Prostate Symptom Score >14.ResultsA total of 253 men (10.9%) developed incident lower urinary tract symptoms. On crude analysis, higher high‐density lipoprotein was associated with a decreased lower urinary tract symptoms risk (hazard ratio 0.89, P = 0.024), whereas total cholesterol and low‐density lipoprotein showed no association. After multivariable adjustment, the association between high‐density lipoprotein and incident lower urinary tract symptoms remained significant (hazard ratio 0.89, P = 0.044), whereas no association was observed for low‐density lipoprotein (P = 0.611). There was a trend for higher cholesterol to be linked with higher lower urinary tract symptoms risk, though this was not statistically significant (hazard ratio 1.04, P = 0.054). A higher cholesterol : high‐density lipoprotein ratio was associated with increased lower urinary tract symptoms risk on crude (hazard ratio 1.11, P = 0.016) and adjusted models (hazard ratio 1.12, P = 0.012).ConclusionsAmong asymptomatic men participating in the REDUCE study, higher cholesterol was associated with increased incident lower urinary tract symptoms risk, though the association was not significant. A higher cholesterol : high‐density lipoprotein ratio was associated with increased incident lower urinary tract symptoms, whereas higher high‐density lipoprotein was protective. These findings suggest dyslipidemia might play a role in lower urinary tract symptoms progression.
Penile Replantation: A Retrospective Analysis of Outcomes and Complications
Morrison, Shane D. , Shakir, Afaaf , Vyas, Krishna S. , Remington, Austin C., Mogni, Benjamin, Wilson, Stelios C., Grant, David , Cho, Daniel , Rahnemai‐Azar, Amir A., Lee, Gordon , Mardini, Samir , Friedrich, Jeffrey B.

Journal of Reconstructive Microsurgery | December 22, 2016 | Volume: 33 | Issue: 04 | Pages: 227-232

10.1055/s-0036-1597567 | PMID 28002849 Get It

Towards the reduction of injury and illness in athletes: defining our research priorities
Finch, Caroline F. , Hewett, Timothy E. , Junge, Astrid , MacAuley, Domhnall, Matheson, Gordon O., McCrory, Paul , Verhagen, Evert , Hewett, Timothy, Bahr, Roald , Drezner, Jonathan A. , Dvořák, Jiří , Engebretsen, Lars , Khan, Karim M. , Verhagen, Evert

British Journal of Sports Medicine | December 21, 2016 | Volume: 51 | Issue: 16 | Pages: 1178-1182

10.1136/bjsports-2016-097042 | PMID 28003237 Get It

Deficient melanocortin-4 receptor causes abnormal reproductive neuroendocrine profile in female mice
Chen, Xiaolin , Huang, Lili , Tan, Hwee Yim Angeline, Li, Hongzhuo , Wan, Ying , Cowley, Michael A. , Veldhuis, Johannes D. , Chen, Chen , Chen, C

Reproduction | December 21, 2016 | Volume: 153 | Issue: 3 | Pages: 267-276

10.1530/rep-16-0341 | PMID 28003536 Get It

Abstract Deletion of the melanocortin-4-receptor (Mc4r) gene in mice causes hyperphagia, followed by hyperinsulinemia, obesity and progressive infertility. Evidence shows that the number of developed corpora lutea is reduced in obese MC4R-knockout (MC4R KO) female mice, but the mechanism is unclear. The effect of hyperphagia and obesity by MC4R KO on pulsatile luteinizing hormone (LH) secretion and ovulation remains unknown. In MC4R KO mice and wild-type littermates (WT LM) during the diestrus period throughout different ages, we examined and monitored their metabolic status, pulsatile LH profiles, follicular morphology and the number of corpora lutea. MC4R KO mice were hyperphagic, obese, hyperglycemic, hyperinsulinemic and demonstrated insulin resistance and hepatic steatosis. Irregular estrous cycles and significant changes in the LH secretion profiles were observed in sexually matured 16- to 28-week MC4R KO mice, without any difference in testosterone levels. In addition, MC4R KO mice at 16 weeks of age had significantly fewer corpora lutea than same age WT LM mice. The ovary examinations of MC4R KO mice at 28 weeks of age showed predominantly antral and preovulatory follicles with no corpora lutea. These findings were consistent with the decrease in total, pulsatile, mass and basal LH releases in MC4R KO mice. The characteristics of hormone profiles in obese MC4R KO mice indicate that MC4R plays an important role in regulating LH release, ovulation and reproductive ability probably via hyperphagia-induced obesity. Further study of correlation between metabolic and reproductive regulatory hormones is warranted to dissect the pathological mechanism underlying obesity-induced infertility. Free Chinese abstract: A Chinese translation of this abstract is freely available at http://www.reproduction-online.org/content/153/3/267/suppl/DC1.
Incidence and clinical characteristics of transfusion‐associated circulatory overload using an active surveillance algorithm
Triulzi, Darrell J., Gottschall, Jerome L. , Chowdhury, Dhuly , Kor, Daryl J. , Looney, Mark R. , Matthay, Michael A. , Kleinman, Steven , Brambilla, Donald , Murphy, Edward L. , (REDS‐III), the NHLBI Recipient Epidemiology and Donor Evaluation Study‐III, Roubinian, Nareg H. , Hendrickson, Jeanne E. , (REDS‐III), the NHLBI Recipient Epidemiology and Donor Evaluation Study‐III

Vox Sanguinis | December 21, 2016 | Volume: 112 | Issue: 1 | Pages: 56-63

10.1111/vox.12466 | PMID 28001313 Get It

BackgroundThe concordance of haemovigilance criteria developed for surveillance of transfusion‐associated circulatory overload (TACO) with its clinical diagnosis has not been assessed. In a pilot study to evaluate an electronic screening algorithm, we sought to examine TACO incidence and application of haemovigilance criteria in patients with post‐transfusion pulmonary oedema.Study Design and MethodsFrom June to September 2014, all transfused adult inpatients at four academic hospitals were screened with an algorithm identifying chest radiographs ordered within 12 h of blood component release. Patients with post‐transfusion pulmonary oedema underwent case adjudication by an expert panel. TACO incidence was calculated, and clinical characteristics were compared with other causes of post‐transfusion pulmonary oedema.ResultsAmong 4932 transfused patients, there were 3412 algorithm alerts, 50 cases of TACO and 47 other causes of pulmonary oedema. TACO incidence was 1 case per 100 patients transfused. TACO classification based on two sets of haemovigilance criteria (National Healthcare Safety Network and proposed revised International Society for Blood Transfusion) was concordant with expert panel diagnosis in 57% and 54% of reviewed cases, respectively. Although the majority of clinical parameters did not differentiate expert panel adjudicated TACO from other cases, improved oxygenation within 24 h of transfusion did (P = 0·01).ConclusionsThe incidence of TACO was similar to that observed in prior studies utilizing active surveillance. Case classification by haemovigilance criteria was frequently discordant with clinical diagnoses of TACO in patients with post‐transfusion pulmonary oedema. Improvements in oxygenation within 24 h of transfusion merit further evaluation in the diagnosis of TACO.
Quantification of the IgG2/4 kappa Monoclonal Therapeutic Eculizumab from Serum Using Isotype Specific Affinity Purification and Microflow LC-ESI-Q-TOF Mass Spectrometry
Ladwig, Paula M. , Barnidge, David R. , Willrich, Maria A V, Willrich, Maria Alice V.

Journal of the American Society for Mass Spectrometry | December 21, 2016 | Volume: 28 | Issue: 5 | Pages: 811-817

10.1007/s13361-016-1566-y | PMID 28004336 Get It

Pulmonary artery sarcoma mimicking pulmonary embolism: a case series
Srivali, Narat , Yi, Eunhee S. , Ryu, Jay H. , Ryu, Jay H , Srivali, Narat

QJM: An International Journal of Medicine | December 21, 2016 | Volume: 110 | Issue: 5 | Pages: 283-286

10.1093/qjmed/hcw232 | PMID 28040708 Get It

Summary Background: Pulmonary artery sarcoma (PAS) is a rare malignant neoplasm with an aggressive behavior and often difficult to distinguish from pulmonary thromboembolic disease. Aim: To assess the demographic, clinical, and radiological characteristics of PAS and clinical course. Design and Methods: We retrospectively identified and analyzed all patients with PAS seen at Mayo Clinic in Rochester, Minnesota, between January 1, 1996 and July 31, 2015. Results: Of nine patients (5 women and 4 men; median age 55 years [range, 24–74 years]), eight were diagnosed while alive with surgical (n = 6) or catheter-based endovascular biopsy (n = 2); the remaining patient was diagnosed at postmortem examination. All tumors manifested on CT as filling defect in the main, right or left pulmonary artery and were not associated with peripheral filling defects in seven patients. Seven patients were initially treated with anticoagulant therapy for presumed PE; two patients were suspected to have tumor based on constrictive or expanding effect seen on CT. Five patients died after a mean duration of 2.1 years (10 months–4.25 years) after diagnosis. Two patients are alive with recurrence and metastases of the disease 23 and 27 months after diagnosis, respectively; one remaining patient is alive and disease-free 116 months after diagnosis. Conclusions: Although PAS is associated with a poor prognosis, long-term survival is possible and can be improved by early diagnosis and prompt surgical resection. Atypical appearance on CT including central mass-like lesion without peripheral emboli and constrictive or expanding effect should raise suspicion of PAS.
Assessing composition and structure of soft biphasic media from Kelvin–Voigt fractional derivative model parameters 4
Zhang, Hongmei , Wang, Yue , Fatemi, Mostafa , Insana, Michael F. , Wang, Yue, Fatemi, Mostafa

Measurement Science and Technology | December 21, 2016 | Volume: 28 | Issue: 3 | Pages: 035703

10.1088/1361-6501/aa5531 | PMID 28239236 Get It

Abstract Kelvin–Voigt fractional derivative (KVFD) model parameters have been used to describe viscoelastic properties of soft tissues. However, translating model parameters into a concise set of intrinsic mechanical properties related to tissue composition and structure remains challenging. This paper begins by exploring these relationships using a biphasic emulsion materials with known composition. Mechanical properties are measured by analyzing data from two indentation techniques—ramp-stress relaxation and load-unload hysteresis tests. Material composition is predictably correlated with viscoelastic model parameters. Model parameters estimated from the tests reveal that elastic modulus E 0 closely approximates the shear modulus for pure gelatin. Fractional-order parameter α and time constant τ vary monotonically with the volume fraction of the material’s fluid component. α characterizes medium fluidity and the rate of energy dissipation, and τ is a viscous time constant. Numerical simulations suggest that the viscous coefficient η is proportional to the energy lost during quasi-static force-displacement cycles, E A . The slope of E A versus η is determined by α and the applied indentation ramp time T r . Experimental measurements from phantom and ex vivo liver data show close agreement with theoretical predictions of the η − E A relation. The relative error is less than 20% for emulsions 22% for liver. We find that KVFD model parameters form a concise features space for biphasic medium characterization that described time-varying mechanical properties.
Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP
Kopec, Michael, Duma, Andreas , Helwani, Mohammad A. , Brown, Jamie , Brown, Frank, Gage, Brian F. , Gibson, David W., Novak, Eric, Jaffe, Allan S. , Apple, Fred S. , Scott, Mitchell G., Nägele, Peter , Miller, J. Philip , Jaffe, Allan S.

Anesthesia & Analgesia | December 21, 2016 | Volume: 124 | Issue: 2 | Pages: 398-405

10.1213/ane.0000000000001736 | PMID 28002165 Get It

BACKGROUND: This study sought to determine whether preoperatively measured high-sensitivity cardiac troponin T (hs-cTnT) and N -terminal pro-brain natriuretic peptide (NT-proBNP) improve cardiac risk prediction in patients undergoing major noncardiac surgery compared with the standard risk indices. METHODS: In this ancillary study to the Vitamins in Nitrous Oxide trial, patients were included who had preoperative hs-cTnT and NT-proBNP measured (n = 572). Study outcome was the incidence of postoperative myocardial infarction (MI) within the first 3 postoperative days. hs-cTnT was considered elevated if >14 ng/L and NT-proBNP if >300 ng/L. Additional cutoff values were investigated on the basis of receiver operating characteristic statistics. Biomarker risk prediction was compared with Lee’s Revised Cardiac Risk Index (RCRI) with the use of standard methods and net reclassification index. RESULTS: The addition of hs-cTnT (>14 ng/L) and NT-proBNP (>300 ng/L) to RCRI significantly improved the prediction of postoperative MI (event rate 30/572 [5.2%], Area under the receiver operating characteristic curve increased from 0.590 to 0.716 with a 0.66 net reclassification index [95% confidence interval 0.32–0.99], P < .001). The use of 108 ng/L as a cutoff for NT-proBNP improved sensitivity compared with 300 ng/L (0.87 vs 0.53). Sensitivity, specificity, positive, and negative predictive value for hs-cTnT were 0.70, 0.60, 0.09, and 0.97 and for NT-proBNP were 0.53, 0.68, 0.08, and 0.96. CONCLUSIONS: The addition of cardiac biomarkers hs-cTnT and NT-proBNP to RCRI improves the prediction of adverse cardiac events in the immediate postoperative period after major noncardiac surgery. The high negative predictive value of preoperative hs-cTnT and NT-proBNP suggest usefulness as a “rule-out” test to confirm low risk of postoperative MI.
Update on pharmacotherapies for cholestatic liver disease
Ali, Ahmad H. , Tabibian, James H. , Lindor, Keith D. , Tabibian, James H

Hepatology Communications | December 21, 2016 | Volume: 1 | Issue: 1 | Pages: 7-17

10.1002/hep4.1013 | PMID 29404429 Get It

Cholestatic liver diseases are conditions with impaired bile formation and/or flow due to genetic, immunologic, environmental, or other causes. Unless successfully treated, this can lead to chronic liver injury and end‐stage liver disease. Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) embody the most prominent adult cholestatic liver diseases with regard to incidence, morbidity, and mortality. A considerable proportion of patients with PBC and PSC experience progressive liver disease and ultimately liver‐related death due to a paucity of effective pharmacotherapy; however, novel pharmacologic developments offer substantial promise in this regard. Here, we provide a brief review and update on current and emerging pharmacotherapies for PBC and PSC. (Hepatology Communications 2017;1:7–17)